10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001683168-21-005469`
Period End Date	20210930
Filing Date	20211112
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	xenetic_i10q-093021_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 56 Cash Flow Statement 44 Stockholders Equity 30

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$19.70M	USD	Point-in-time
Cash	`Cash`	$11.53M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$878.24K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$841.96K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.58M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.37M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$704.43K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$809.99K	USD	Point-in-time
Total assets	`Assets`	$13.18M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.77M	shares	Point-in-time
Total assets	`Assets`	$21.29M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.41M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.75M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.39M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$248.49K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$327.40K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$873.01K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$609.53K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.12M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$936.93K	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	-	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$27.04K	USD	Point-in-time
Total liabilities	`Liabilities`	$963.97K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.12M	USD	Point-in-time
Commitments (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock, Value, Issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, Value, Issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized as of September 30, 2021 and December 31, 2020; 13,413,013 and 8,772,198 shares issued as of September 30, 2021 and December 31, 2020, respectively; 13,386,022 and 8,745,207 shares outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$8.77K	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized as of September 30, 2021 and December 31, 2020; 13,413,013 and 8,772,198 shares issued as of September 30, 2021 and December 31, 2020, respectively; 13,386,022 and 8,745,207 shares outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$13.41K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$194.13M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$205.88M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-180.71M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-176.90M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.22M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.36M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.16M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$17.21M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.29M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$13.18M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`Revenues`	$349.27K	USD	1 Quarter
Total revenue	`Revenues`	$285.61K	USD	3 Qtrs
Total revenue	`Revenues`	$828.09K	USD	3 Qtrs
Total revenue	`Revenues`	$115.93K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.24M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$573.06K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.93M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$780.15K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$804.15K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$945.12K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.77M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.52M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentCharges`	$9.24M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentCharges`	-	USD	1 Quarter
Asset impairment charges	`AssetImpairmentCharges`	-	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentCharges`	$9.24M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$10.62M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.73M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$4.70M	USD	3 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$13.00M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-12.72M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.87M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-10.50M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.38M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-2.91K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-1.78K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$643.00	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$585.00	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$71.03K	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$28.03K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$105.04K	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$24.93K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$25.52K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$25.12K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$69.24K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$105.69K	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.35M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.80M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.48M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-12.61M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-2.92M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-2.92M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.69M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.80M	USD	3 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-1.20	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-1.55	USD	3 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	3 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.16M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.22M	shares	3 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.30M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.27M	shares	3 Qtrs

Cash Flow Statement 44 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-3.80M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-9.69M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentCharges`	$9.24M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentCharges`	-	USD	1 Quarter
Asset impairment charges	`AssetImpairmentCharges`	-	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentCharges`	$9.24M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	-	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-2.92M	USD	3 Qtrs
Depreciation	`Depreciation`	-	USD	3 Qtrs
Depreciation	`Depreciation`	$757.00	USD	3 Qtrs
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$26.20K	USD	3 Qtrs
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$20.04K	USD	3 Qtrs
Gain on settlement with vendor	`GainOnSettlementWithVendor`	-	USD	3 Qtrs
Gain on settlement with vendor	`GainOnSettlementWithVendor`	$-143.64K	USD	3 Qtrs
Share-based expense	`ShareBasedCompensation`	$388.13K	USD	3 Qtrs
Share-based expense	`ShareBasedCompensation`	$297.34K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-43.07K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-273.05K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-483.05K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$157.52K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.28M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.31M	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$11.45M	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$3.68K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$11.45M	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$8.18M	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-3.31M	USD	3 Qtrs
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.70M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.53M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.05M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.70M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.53M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.05M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Issuance of common stock to vendor	`IssuanceOfCommonStockToVendor`	$1.00	USD	3 Qtrs
Issuance of common stock to vendor	`IssuanceOfCommonStockToVendor`	$7.00	USD	3 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$229.00	USD	3 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$4.00	USD	3 Qtrs

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$9.95M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$12.22M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$15.36M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$7.91M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$20.16M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Issuance of common stock and warrants, net of issuance costs	`IssuanceOfCommonStockAndWarrantsNetOfIssuanceCostsValue`	$11.45M	USD	3 Qtrs
Issuance of common stock and warrants, net of issuance costs	`IssuanceOfCommonStockAndWarrantsNetOfIssuanceCostsValue`	$11.45M	USD	1 Quarter
Exercise of pre-funded warrants	`ExerciseOfPrefundedWarrantsValue`	$3.68K	USD	3 Qtrs
Exercise of pre-funded warrants	`ExerciseOfPrefundedWarrantsValue`	$3.68K	USD	1 Quarter
Exercise of purchase warrants	`ExerciseOfPurchaseWarrantsValue`	-	USD	3 Qtrs
Exercise of purchase warrants	`ExerciseOfPurchaseWarrantsValue`	-	USD	3 Qtrs
Exercise of purchase warrants	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Issuance of common stock to vendor	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	3 Qtrs
Issuance of common stock to vendor	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	3 Qtrs
Issuance of common stock to vendor	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$111.13K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$110.80K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$297.34K	USD	3 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$388.13K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.69M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.80M	USD	3 Qtrs
Ending balance, value	`StockholdersEquity`	$9.95M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$12.22M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$15.36M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$7.91M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$20.16M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.